Abstract
Several drug-carrier polymers were synthesized in this program, including polyaspartamides, ester-amine condensation polymers, and polyamidoamines (PAAs). Functionalized polyaspartamides were obtained in 46–73% yield by an aminolytic ring-opening process resulting from the nucleophilic attack of a number of selected amines on polysuccinimide, which in turn was obtained by a high-temperature polycondensation reaction in the presence of phosphoric acid. These polyaspartamides were characterized by inherent viscosities in the range of 8–26 mL g−1. The ester-amine polymers were obtained in 42–71% yield by base-catalyzed polycondensation reactions under controlled conditions of temperature, in DMSO, so as to ensure the incorporation and integrity of unprotected hydroxyl functional groups in the polymer’s main chain. These polymers were characterized by inherent viscosities in the range of 10–13 mL g−1. PAAs were synthesized by the addition of amine nucleophiles across the double bonds of methylene bisacrylamide (Michael-type addition), under carefully controlled experimental conditions to obtain both amide and secondary amine functions in the water-soluble polymeric main chain. They were obtained in 16–29% yield and characterized by inherent viscosities in the range of 20–26 mL g−1. These three types of polymers are perfectly water-soluble polymeric products which are purified by dialysis (12,000 molecular mass cut-off) and freeze-drying. They are of interest as macromolecular carriers for pharmaceuticals and biologically active agents.
Similar content being viewed by others
References
E.W. Neuse, A.G. Perlwitz, S. Schmitt, Water-Soluble Polyamides as Potential Drug Carriers (J. Hüthing & Wepf Verlag, Basel, 1991)
E.G. Hulse, U.S. Patent 2579913 Aug 21, 1956, Chem. Abstr. 25, 167 (1995)
F. Danusso et al., Chimica e Industria 271, 826 (1967)
F. Danuso, P. Ferruti, Synthesis of tertiary amine polymers. Polymer 11(2), 88 (1970)
P. Ferruti, M.A. Marchisio, R. Duncan, Poly(amido-amine)s: biomedical applications. Macromol. Rapid. Commun. 23(5–6), 332 (2002)
A.M. Marchisio et al., Eur. Surg. Res. 3, 240 (1971)
A.M. Marchisio et al., Eur. Surg. Res. 4, 312 (1972)
A.M. Marchisio et al., Experientia 29, 93 (1973)
A. M. Marchisio et al., U.S. Patent 3 865, 723 (1975)
G. Caldwell, E.W. Neuse, S. Afr. J. Chem. 45, 93 (1992)
G. Caldwell, E.W. Neuse, A. Stephanou, J. Appl. Polym. Sci. 50, 393 (1993)
P. Neri, G. Antoni, Macromol. Synth. 8, 25 (1982)
A. Gelasco, S.J. Lippert, in Mettapharmaceuticals I DNA interactions: Topics in Biological Inorganic Chemistry, vol. 1, ed. by M.J. Clarke, P.J. Sadler (Springer, New-York, 1999), p. 1
R. Duncan, in Controlled Drug Delivery, Fundamentals and Applications, 2nd edn. (Marcel Dekker, New York, 1987), p. 599
Acknowledgments
The authors gratefully acknowledge the bursary supports provided by the Foundation for Research Development, NRF, (2007–2008) and Bradlow Postgraduate Awards (2006–2009) of this University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mufula, A.I., Neuse, E.W. Macromolecular Carriers for Methotrexate and Ferrocene in Cancer Chemotherapy. J Inorg Organomet Polym 21, 511–526 (2011). https://doi.org/10.1007/s10904-011-9471-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10904-011-9471-0